Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer.

Ji-Yeon KimHae Hyun JungInsuk SohnSook Young WooHyun ChoEun Yoon ChoJeong Eon LeeSeok Won KimSeok Jin NamYeon Hee ParkJin Seok AhnYoung-Hyuck Im

Published in: Breast cancer research and treatment (2020)

In this study, a 13-gene expression profile in combination with stage precisely predicted distant recurrence of early TNBC. Therefore, this 13-immune-gene signature could help predict TNBC prognosis and provide guidance for treatment as well as the opportunity to develop new targets for immunotherapy in TNBC patients.

Keyphrases

copy number
genome wide
end stage renal disease
genome wide identification
ejection fraction
newly diagnosed
chronic kidney disease
lymph node
prognostic factors
gene expression
genome wide analysis
transcription factor
patient reported
free survival